BIOREGENX, INC. (BRGX) Net margin 2021–2025
BIOREGENX, INC. (BRGX) net profit margin by fiscal year — reported net income divided by reported revenue.
-83.2%FY2025 · since FY2021: -48.8% → -83.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -83.2% | +901.9 pp |
| FY2024 | -985.2% | -879.6 pp |
| FY2023 | -105.5% | +80.2 pp |
| FY2022 | -185.7% | -137.0 pp |
| FY2021 | -48.8% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More BRGX financial trends
BRGX RevenueBRGX Net incomeBRGX Gross profitBRGX Gross marginBRGX Operating incomeBRGX Operating marginBRGX Operating cash flowBRGX Free cash flowBRGX Capital expendituresBRGX Return on equityBRGX Stock buybacksBRGX Dividends paidBRGX Total assetsBRGX Total liabilitiesBRGX Shareholders’ equityBRGX overview →